Metric Finance
LearnFAQ
LearnFAQ

Learn / TLRY

NASDAQ: TLRY

Tilray Brands (TLRY) stock, explained like you're 5

Tilray Brands trades on the Nasdaq under the ticker TLRY. It is a small cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 523 million dollars.

Ticker
TLRY
Exchange
Nasdaq
Sector
Healthcare
Industry
Medicinal Chemicals and Botanical Products
Size
Small cap, about 523 million dollars

Is Tilray Brands a small, medium or large cap company?

No. Tilray Brands is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 523 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Tilray Brands makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves TLRY stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? (The Motley Fool)
  • Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.3% Time to Sell? (MarketBeat)
  • Two winners can pick a Georgia concert and get a travel gift card from SweetWater. (Stock Titan)
  • Tilray Brands Inc. stock falls Friday, underperforms market (MarketWatch)
  • TLRY Oct 2026 8.000 put (TLRY261030P00008000) Stock Price, News, Quote & History (Yahoo! Finance Canada)

Follow TLRY in your daily brief

Each trading day at 5 PM ET we post what happened to Tilray Brands and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow TLRY

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Tilray Brands stock

What does Tilray Brands do?

Tilray Brands trades on the Nasdaq under the ticker TLRY. It is a small cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 523 million dollars.

What is the ticker symbol for Tilray Brands?

Tilray Brands trades under the ticker TLRY on the Nasdaq.

What is Tilray Brands's market cap?

Tilray Brands is a small cap stock with a market cap of about 523 million dollars.

How does Tilray Brands make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves TLRY stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow TLRY stock every day?

Add TLRY to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow TLRY daily

A free brief on Tilray Brands and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTI · British American Tobacco p.l.c.
  • DFTX · Definium Therapeutics
  • RGC · Regencell Bioscience Holdings Ltd
  • RLX · RLX Technology

Similar stocks

  • BTIBritish American Tobacco p.l.c.
  • DFTXDefinium Therapeutics
  • RGCRegencell Bioscience Holdings Ltd
  • RLXRLX Technology

Compare TLRY: TLRY vs BTI, TLRY vs DFTX, TLRY vs RGC

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed